Benjamin E. Leiby

8.1k total citations
234 papers, 5.4k citations indexed

About

Benjamin E. Leiby is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Ophthalmology. According to data from OpenAlex, Benjamin E. Leiby has authored 234 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 48 papers in Pulmonary and Respiratory Medicine and 44 papers in Ophthalmology. Recurrent topics in Benjamin E. Leiby's work include Glaucoma and retinal disorders (25 papers), Retinal Diseases and Treatments (22 papers) and Pancreatic and Hepatic Oncology Research (18 papers). Benjamin E. Leiby is often cited by papers focused on Glaucoma and retinal disorders (25 papers), Retinal Diseases and Treatments (22 papers) and Pancreatic and Hepatic Oncology Research (18 papers). Benjamin E. Leiby collaborates with scholars based in United States, Finland and Canada. Benjamin E. Leiby's co-authors include Barry W. Rovner, Robin J. Casten, Charles J. Yeo, William Tasman, Ralph J. Marino, Mark T. Hegel, Marja T. Nevalainen, Rodrigo Cavallazzi, Edward O. Bixler and Amyn Hirani and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Benjamin E. Leiby

224 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin E. Leiby United States 39 1.3k 1.0k 985 836 681 234 5.4k
Margery Gass United States 46 2.1k 1.7× 682 0.7× 465 0.5× 1.1k 1.3× 456 0.7× 110 12.4k
Michel Cucherat France 40 726 0.6× 570 0.6× 1.3k 1.3× 923 1.1× 1.0k 1.5× 182 8.1k
Lori Lyn Price United States 48 491 0.4× 653 0.6× 2.2k 2.2× 438 0.5× 1.3k 1.9× 251 9.1k
Fernando Rivadeneira Netherlands 56 1.2k 1.0× 793 0.8× 1.4k 1.5× 3.0k 3.6× 987 1.4× 274 10.8k
Geir Egil Eide Norway 45 1.2k 0.9× 1.9k 1.8× 1.0k 1.0× 595 0.7× 610 0.9× 193 6.3k
Christoph Engel Germany 39 1.3k 1.0× 505 0.5× 557 0.6× 876 1.0× 800 1.2× 221 5.7k
Howard Amital Israel 57 639 0.5× 898 0.9× 982 1.0× 1.4k 1.6× 1.5k 2.3× 401 11.5k
Nancy N. Diehl United States 44 1.0k 0.8× 1.1k 1.1× 1.5k 1.6× 469 0.6× 2.0k 3.0× 191 7.8k
Michael G. Heckman United States 48 1.1k 0.9× 1.6k 1.6× 2.5k 2.5× 1.0k 1.2× 880 1.3× 344 8.2k
Carla L. Warneke United States 38 2.4k 2.0× 1.1k 1.1× 600 0.6× 1.1k 1.3× 501 0.7× 104 5.1k

Countries citing papers authored by Benjamin E. Leiby

Since Specialization
Citations

This map shows the geographic impact of Benjamin E. Leiby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin E. Leiby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin E. Leiby more than expected).

Fields of papers citing papers by Benjamin E. Leiby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin E. Leiby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin E. Leiby. The network helps show where Benjamin E. Leiby may publish in the future.

Co-authorship network of co-authors of Benjamin E. Leiby

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin E. Leiby. A scholar is included among the top collaborators of Benjamin E. Leiby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin E. Leiby. Benjamin E. Leiby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCarthy, Danielle M., Sara Malone, Dimitrios Papanagnou, et al.. (2025). Targeted EHR-based communication of diagnostic uncertainty (TECU) in the emergency department: Protocol for an effectiveness implementation trial. Contemporary Clinical Trials. 153. 107910–107910.
2.
Leiby, Benjamin E., Usama Gergis, Joanne Filicko-O’Hara, et al.. (2024). A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose. European Journal Of Haematology. 113(3). 283–289. 1 indexed citations
3.
Wilson, L, Bernard L. Jones, Moyed Miften, et al.. (2024). Results of a Prospective Trial to Evaluate Novel Lung Function Imaging for Lung Cancer Surgery. International Journal of Radiation Oncology*Biology*Physics. 120(2). S53–S53.
4.
Edwards, Dylan J., Charles Y. Liu, Kari Dunning, et al.. (2023). Electric Field Navigated 1-Hz rTMS for Poststroke Motor Recovery: The E-FIT Randomized Controlled Trial. Stroke. 54(9). 2254–2264. 8 indexed citations
5.
Testa, Anna, Stephen Lin, Tami Von Schalscha, et al.. (2023). Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer. Matrix Biology. 124. 49–62. 6 indexed citations
6.
Ohri, Nitin, et al.. (2023). Remote Activity Monitoring and Electronic Patient-Reported Outcomes Collection During Radiotherapy for Head and Neck Cancer: A Pilot Study. JCO Clinical Cancer Informatics. 7(7). e2200132–e2200132. 3 indexed citations
7.
Quinn, Zachary L., Benjamin E. Leiby, Guru Sonpavde, et al.. (2022). Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. Clinical Cancer Research. 29(1). 50–59. 18 indexed citations
8.
Shen, He, Eleonora Sementino, Zhijiu Zhong, et al.. (2022). BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma. Cancer Letters. 547. 215885–215885. 15 indexed citations
9.
Grosso, Dolores, Benjamin E. Leiby, Lindsay Wilde, et al.. (2022). A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation. Transplantation and Cellular Therapy. 28(12). 831.e1–831.e7. 3 indexed citations
10.
Leiby, Benjamin E., James S. Harrop, Lubdha M. Shah, et al.. (2021). Validation of the National Institute of Neurological Disorders and Stroke Spinal Cord Injury MRI Common Data Elements Instrument. American Journal of Neuroradiology. 42(4). 787–793. 4 indexed citations
11.
Hark, Lisa, Jennifer Adeghate, L. Jay Katz, et al.. (2019). Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study: Cataract Classifications Following Eye Screening. Telemedicine Journal and e-Health. 26(8). 992–1000. 8 indexed citations
12.
Nevler, Avinoam, Alexander J. Muller, Erika Sutanto‐Ward, et al.. (2018). Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS -Driven Sporadic Pancreatic Cancers. Clinical Cancer Research. 25(2). 724–734. 41 indexed citations
13.
McNair, Christopher, Kexin Xu, Amy C. Mandigo, et al.. (2017). Differential impact of RB status on E2F1 reprogramming in human cancer. Journal of Clinical Investigation. 128(1). 341–358. 70 indexed citations
14.
Gu, Lei, Paraskevi Vogiatzi, Ana L. Romero-Weaver, et al.. (2014). Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6–Induced Experimental Prostate Cancer Metastases Formation. Molecular Cancer Therapeutics. 13(5). 1246–1258. 35 indexed citations
15.
Leiby, Benjamin E., et al.. (2014). A Comparative Study of the Water Drinking Test in Eyes with Open-Angle Glaucoma and Prior Trabeculectomy or Tube Shunt. Investigative Ophthalmology & Visual Science. 55(13). 125–125.
16.
Murchison, Ann P., Lisa Hark, Yang Dai, et al.. (2014). Improving Eye Care Follow-Up Adherence in Patients with Diabetes: The Effectiveness of Patient Contracts in a Community-Based Eye Screening. Investigative Ophthalmology & Visual Science. 55(13). 6094–6094. 1 indexed citations
17.
Hark, Lisa, Benjamin E. Leiby, Yang Dai, et al.. (2014). Ophthalmic Patients' Utilization of Technology and Social Media: An Assessment to Improve Quality of Care. Telemedicine Journal and e-Health. 20(10). 887–892. 13 indexed citations
18.
Gu, Lei, Zhiyong Liao, David T. Hoang, et al.. (2013). Pharmacologic Inhibition of Jak2–Stat5 Signaling By Jak2 Inhibitor AZD1480 Potently Suppresses Growth of Both Primary and Castrate-Resistant Prostate Cancer. Clinical Cancer Research. 19(20). 5658–5674. 48 indexed citations
19.
Zangalli, Camila, Ann P. Murchison, Yang Dai, et al.. (2013). Educational and Personal Reminders to Improve Follow-Up to Vision Care in Patients with Diabetes: A Prospective, Randomized Trial. Investigative Ophthalmology & Visual Science. 54(15). 215–215. 1 indexed citations
20.
Ad, Voichita Bar, Matthew E. Witek, Benjamin E. Leiby, et al.. (2012). Treatment-related Esophagitis for Patients With Locoregionally Advanced Non-small Cell Lung Cancer Treated With Involved-Field Radiation Therapy and Concurrent Chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 84(3). S551–S552. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026